Gefitinib targets ZAP-70-expressing chronic lymphocytic leukemia cells and inhibits B-cell receptor signaling.
about
Chronic Lymphocytic Leukemia: Exploiting Vulnerabilities with Targeted AgentsTargeting chronic lymphocytic leukemia cells in the tumor microenviroment: A review of the in vitro and clinical trials to dateGenetic aberrations in small B-cell lymphomas and leukemias: molecular pathology, clinical relevance and therapeutic targets.Neurotensin receptor type 2 protects B-cell chronic lymphocytic leukemia cells from apoptosis.Role for ZAP-70 Signaling in the Differential Effector Functions of Rituximab and Obinutuzumab (GA101) in Chronic Lymphocytic Leukemia B Cells.
P2860
Gefitinib targets ZAP-70-expressing chronic lymphocytic leukemia cells and inhibits B-cell receptor signaling.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Gefitinib targets ZAP-70-expre ...... its B-cell receptor signaling.
@ast
Gefitinib targets ZAP-70-expre ...... its B-cell receptor signaling.
@en
type
label
Gefitinib targets ZAP-70-expre ...... its B-cell receptor signaling.
@ast
Gefitinib targets ZAP-70-expre ...... its B-cell receptor signaling.
@en
prefLabel
Gefitinib targets ZAP-70-expre ...... its B-cell receptor signaling.
@ast
Gefitinib targets ZAP-70-expre ...... its B-cell receptor signaling.
@en
P2093
P2860
P356
P1476
Gefitinib targets ZAP-70-expre ...... its B-cell receptor signaling.
@en
P2093
J B Johnston
R F Dielschneider
S B Gibson
P2860
P2888
P356
10.1038/CDDIS.2014.391
P577
2014-10-02T00:00:00Z
P5875
P6179
1037834401